Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5401_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
284 Herbal Pharmacopeia
51. Gogate PR, Kabadi AM. A review of applications of cavitation in biochemical engineering/biotechnol-
ogy. Biochemical Engineering Journal. 2009;44(1):60–72.
52. Bouchemal K, Briançon S, Perrier E, Fessi H. Nano- emulsion formulation using spontaneous emulsication:
Solvent, oil and surfactant optimisation. International Journal of Pharmaceutics. 2004;280(1–2):241–51.
53. Zeeb B, Herz E, McClements DJ, Weiss J. Impact of alcohols on the formation and stability of protein-
stabilized nanoemulsions. Journal of Colloid and Interface Science. 2014;433:196–203.
54. Guan Y, Wu J, Zhong Q. Eugenol improves physical and chemical stabilities of nanoemulsions loaded
with β-carotene. Food Chemistry. 2016;194:787–96.
55. McClements DJ. Nanoemulsion- based oral delivery systems for lipophilic bioactive components:
Nutraceuticals and pharmaceuticals. Therapeutic Delivery. 2013;4(7):841–57.
56. Lee SJ, Choi SJ, Li Y, Decker EA, McClements DJ. Protein- stabilized nanoemulsions and emulsions:
Comparison of physicochemical stability, lipid oxidation, and lipase digestibility. Journal of Agricultural and Food Chemistry. 2011;59(1):415–27.
57. Qian C, Decker EA, Xiao H, McClements DJ. Physical and chemical stability of β-carotene- enriched nanoemul-
sions: Inuence of pH, ionic strength, temperature, and emulsier type. Food Chemistry. 2012;132(3):1221–9.
58. Milovanovic M, Arsenijevic A, Milovanovic J, Kanjevac T, Arsenijevic N. Nanoparticles in Antiviral
Therapy. Elsevier; 2017. p. 383–410.
59. Bose A, Roy Burman D, Sikdar B, Patra P. Nanomicelles: Types, properties and applications in drug
delivery. IET Nanobiotechnology. 2021;15(1):19–27.
60. Kazunori K, Glenn S K, Masayuki Y, Teruo O, Yasuhisa S. Block copolymer micelles as vehicles for drug
delivery. Journal of Controlled Release. 1993;24(1–3):119–32.
61. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classi-
cation: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 1995;12(3):413–20.
62. Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, et al. Strategies to
address low drug solubility in discovery and development. Pharmacological Reviews. 2013;65(1):315–499.
63. Bhalani DV, Nutan B, Kumar A, Singh Chandel AK. Bioavailability enhancement techniques for poorly
aqueous soluble drugs and therapeutics. Biomedicines. 2022;10(9):2055.
64. Chandel AKS, Nutan B, Raval IH, Jewrajka SK. Self- Assembly of Partially Alkylated Dextran- graft-
poly[(2-dimethylamino)ethyl methacrylate] Copolymer Facilitating Hydrophobic/Hydrophilic Drug Delivery and Improving Conetwork Hydrogel Properties. Biomacromolecules. 2018;19(4):1142–53.
65. Chandel AKS, Bhingradiya N. Therapeutic efcacy of herbal formulations through novel drug delivery
systems. IGI Global; 2021. p. 1–42.
66. Gaucher G, Dufresne M- H, Sant VP, Kang N, Maysinger D, Leroux J- C. Block copolymer micelles:
Preparation, characterization and application in drug delivery. Journal of Controlled Release. 2005;109(1–3):169–88.
67. Xing H, Wang H, Wu B, Zhang X. Lipid nanoparticles for the delivery of active natural medicines.
Current Pharmaceutical Design. 2018;23(43):6705–13.
68. Muchow M, Maincent P, Müller RH. Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®)
for Oral Drug Delivery. Drug Development and Industrial Pharmacy. 2008;34(12):1394–405.
69. Andrade LM, De Fátima Reis C, Maione- Silva L, Anjos JLV, Alonso A, Serpa RC, et al. Impact of lipid
dynamic behavior on physical stability, in vitro release and skin permeation of genistein- loaded lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 2014;88(1):40–7.
70. Poonia N, Kharb R, Lather V, Pandita D. Nanostructured lipid carriers: Versatile oral delivery vehicle.
Future Science OA. 2016;2(3):135.
71. Neslihan Gursoy R, Benita S. Self- emulsifying drug delivery systems (SEDDS) for improved oral deliv-
ery of lipophilic drugs. Biomedicine & Pharmacotherapy. 2004;58(3):173–82.
72. Vemula VR, Lagishetty V, Lingala S. Solubility enhancement techniques. International Journal of
Pharmaceutical Sciences Review and Research. 2010;5(1):41–51.
73. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. Journal of
Pharmaceutical Sciences. 1971;60(9):1281–302.
74. Yousaf AM, Malik UR, Shahzad Y, Mahmood T, Hussain T. Silymarin- laden PVP- PEG polymeric com-
posite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization. Journal of Pharmaceutical Analysis. 2019;9(1):34–9.
Enhanced Bioavailability of Herbal Extracts using Nanocarriers 285
75. Gupta T, Singh J, Kaur S, Sandhu S, Singh G, Kaur IP. Enhancing bioavailability and stability of curcumin
using solid lipid nanoparticles (CLEN): A covenant for its effectiveness. Frontiers in Bioengineering and Biotechnology. 2020;879.
76. Harwansh RK, Deshmukh R, Rahman MA. Nanoemulsion: Promising nanocarrier system for delivery of
herbal bioactives. Journal of Drug Delivery Science and Technology. 2019;51:224–33.
77. Saleh A, Akkus-Dagdeviren ZB, Haddadzadegan S, Wibel R, Bernkop- Schnürch A. Peptide antibiotic–
polyphosphate nanoparticles: A promising strategy to overcome the enzymatic and mucus barrier of the intestine. Biomacromolecules. 2023;24(6):2587–95.
78. Bilia AR, Bergonzi MC, Guccione C, Manconi M, Fadda AM, Sinico C. Vesicles and micelles: Two
versatile vectors for the delivery of natural products. Journal of Drug Delivery Science and Technology. 2016;32:241–55.
79. Bergonzi MC, Isacchi B, Bilia AR. Octanoyl- 6–O- ascorbic acid: An efcient antioxidant with potent
solubilising properties The case of active constituents from Saint John’s wort. Journal of Drug Delivery Science and Technology. 2013;23(5):505–9.
80. Kakkar V, Singh S, Singla D, Kaur IP. Exploring solid lipid nanoparticles to enhance the oral bioavail-
ability of curcumin. Molecular Nutrition & Food Research. 2011;55(3):495–503.
81. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle- based
drug and gene delivery. Advanced Drug Delivery Reviews. 2016;99:28–51.
82. Misra SK, Pathak K. Targeted drug delivery approaches for the management of tumors. Tumor Discovery.
2023;2(3):1356.
83. Chakraborty G, Meher M, Dash S, Rout RN, Pradhan S, Sahoo D. Strategies for targeted delivery via
structurally variant polymeric nanocarriers. ChemistrySelect. 2023;8(29):e202301626.
84. Zeeshan F, Dua K. Pharmacokinetics and pharmacodynamics of the advanced drug delivery systems.
Elsevier; 2020. p. 551–71.
85. McDonald TO, Giardiello M, Martin P, Siccardi M, Liptrott NJ, Smith D, et al. Antiretroviral solid drug
nanoparticles with enhanced oral bioavailability: Production, characterization, and in vitro–in vivo cor­relation. Advanced Healthcare Materials. 2014;3(3):400–11.
86. Le H, Karakasyan C, Jouenne T, Le Cerf D, Dé E. Application of polymeric nanocarriers for enhanc-
ing the bioavailability of antibiotics at the target site and overcoming antimicrobial resistance. Applied Sciences. 2021;11(22):10695.
87. Lim SB, Banerjee A, Önyüksel H. Improvement of drug safety by the use of lipid- based nanocarriers.
Journal of Controlled Release. 2012;163(1):34–45.
88. Alghamdi MA, Fallica AN, Virzì N, Kesharwani P, Pittalà V, Greish K. The promise of nanotechnology
in personalized medicine. Journal of Personalized Medicine. 2022;12(5):673.
89. Rombolà L, Scuteri D, Marilisa S, Watanabe C, Morrone LA, Bagetta G, et al. Pharmacokinetic interac-
tions between herbal medicines and drugs: Their mechanisms and clinical relevance. Life. 2020;10(7):106.
90. Hassen G, Belete G, Carrera KG, Iriowen RO, Araya H, Alemu T, et al. Clinical implications of herbal
supplements in conventional medical practice: A US perspective. Cureus. 2022;14(7), e26893.
91. Chavda VP, Nalla LV, Balar P, Bezbaruah R, Apostolopoulos V, Singla RK, et al. Advanced phytochemical-
based nanocarrier systems for the treatment of breast cancer. Cancers. 2023;15(4):1023.
92. Alam MK. Nanocarrier- based drug delivery systems using microuidic- assisted techniques. Advanced
NanoBiomed Research. 2023;3(11):2300041.
93. Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS. Nanocarrier drug delivery sys-
tems: Characterization, limitations, future perspectives and implementation of articial intelligence. Pharmaceutics. 2022;14(4):883.
94. Salih WA, Al- Taie AA. Strategies of nanocarrier- based therapeutic drug delivery. Al- Nahrain Journal for
Engineering Sciences. 2023;26(4):365–73.
95. Kumar R. Nanotechnology in herbal medicine: Challenges and future perspectives. Nanotechnology in
Herbal Medicine: Elsevier; 2023. p. 515–48.
96. Setia A, Vallamkonda B, Challa RR, Mehata AK, Badgujar P, Muthu MS. Herbal theranostics: Controlled,
targeted delivery and imaging of herbal molecules. Nanotheranostics. 2024;8(3):344.
97. Yadav D, Suri S, Choudhary AA, Sikender M, Hemant B, Beg N. Novel approach: Herbal remedies and
natural products in pharmaceutical science as nano drug delivery systems. Int J Pharm Tech. 2011;3(3): 3092–116.
286 Herbal Pharmacopeia
98. Sharma A, Mitkare S, Moon R. Multicomponent herbal therapy: A review. International Journal of
Pharmaceutical Sciences Review and Research 2011;6:185–7.
99. Zhang J- F, Hou S- X, Liu H- L. Comparison of preparing two polylactide nanoparticles loaded lipophilic
anti- cancer herb drug by nanoprecipitation method. Zhongguo Zhong yao za zhi= Zhongguo Zhongyao Zazhi= China Journal of Chinese Materia Medica. 2007;32(4):303–6.
100. Li Y, Dong L, Jia A, Chang X, Xue H. Preparation and characterization of solid lipid nanoparticles loaded
traditional Chinese medicine. International Journal of Biological Macromolecules. 2006;38(3–5):296–9.
101. Ansari S, Islam F, Sameem M. Inuence of nanotechnology on herbal drugs: A Review. Journal of
Advanced Pharmaceutical Technology & Research. 2012;3(3):142–6.
102. Shah N, Kumari M, Sadhu P, Talele C, Rajput HS, Sapra R. Nano- herbal innovations: Precision in thera-
peutic delivery. Journal of Advanced Zoology. 2024;45(1), 576–581.
Herbal Medicine and
13
Neurological Diseases
Sunil Kumar Kadiri and Prashant Tiwari
Department of Pharmacology, College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India
Samaresh Pal Roy
Department of Pharmacology, Sardar Patel College of Pharmacy, Vidyanagar, Gujarat, India
Suchismita Bhowmik
Department of Community Health Nursing, Manikaka Topawala Institute of Nursing, Charotar University of Science and Technology, Changa, Gujarat, India

13.1 INTRODUCTION TO HERBAL MEDICINE AND NEUROLOGICAL DISEASES

Herbal medicine has been traditionally utilized for centuries across diverse cultures to address a wide assortment of health conditions [1]. The employment of plants and plant- derived substances has coevolved alongside conventional medicine, offering choice or complementary alternatives for managing diseases, like those impacting the neurological system. Neurological afictions encom­pass an expansive spectrum of disorders inuencing the brain, spinal cord, and peripheral nerves [2–4]. These circumstances can vary from neurodegenerative maladies such as Alzheimer’s and Parkinson’s to neurological issues – for example epilepsy, migraines, and multiple sclerosis [5]. Standard treatments regularly involve pharmaceuticals targeting symptoms or slowing the progres­sion of these diseases. Nevertheless, these treatments may come with side effects, leading numerous patients and healthcare providers to explore herbal remedies as supplementary or substitute therapies [6–8]. Herbs such as Ginkgo biloba, St. John’s Wort, and Valerian root have been researched for their potential neuroprotective impacts and their ability to improve cognitive function, mood, and sleep. Ginkgo biloba, for instance, is believed to enhance cognitive function by boosting blood circulation in the brain, while St. John’s Wort is commonly utilized for its antidepressant impacts. The thera­peutic possibility of herbal medicine in neurological diseases lies in the intricate interplay of vari­ous active substances found in plants. These compounds may offer antioxidant, anti- inammatory, and neuroprotective consequences, which are crucial in managing the oxidative stress and swelling that are frequently related to neurological conditions [9]. Despite the promising impacts of herbal medicine, it is essential to approach its employment with caution. The efcacy of many herbal rem­edies is still under investigation, and their interactions with conventional medications are not fully comprehended [10]. Additionally, the standardization of herbal products and the variability in their active components pose substantial challenges to their consistent use in clinical settings.
As interest in herbal medicine continues to grow, further research is necessary to establish the safety, efcacy, and mechanisms of action of these natural treatments in the context of neurological diseases. Healthcare providers should be informed about the potential benets and risks of herbal therapies to guide patients in making well- informed decisions about their treatment options [11].
287
288 Herbal Pharmacopeia

13.1.1 Overview Of Herbal Medicine

Herbal medicine, also known as phytotherapy, involves harnessing nature’s healing gifts from plants and their extracts for therapeutic purposes. It has been practiced for millennia across diverse cultures and remains integral to systems like Ayurveda, traditional Chinese medicine (TCM), and Native American healing practices [12].
13.1.1.1 Key Aspects of Herbal Medicine
Plant sources provide remedies as fresh, dried, or extracted leaves, roots, owers, bark, seeds, and fruits [13]. Active compounds confer benets through alkaloids, avonoids, terpenes, and glyco­sides working anti- inammatory, antimicrobial, antioxidant, and immune- modulating effects. Herbal medicine often adopts a holistic stance to health, focusing on equilibrium of body, mind, and spirit. It considers an individual’s overall wellness, rather than solely treating symptoms [14–18].
Commonly used herbs include: immune- bolstering Echinacea reducing cold duration; St.
John’s Wort, which has anti- depressant and mood- stabilizing actions; energy- enhancing, cognitive- function- boosting ginseng; and anti- inammatory, antioxidant turmeric (Figure
13.1). Similarly, peppermint frequently eases digestion and headaches.
Safety and efcacy matter: while many herbs are safe with proper use, some may interact
dangerously with medications or cause side effects. Seek qualied guidance, especially with regard to health issues or other medications. Modern integration increasingly merges herbal medicine into mainstream care as complementary therapies alongside conventional treatments. This stimulated scientic research into various remedies’ effectiveness and risks. Regulation varies between designating herbal medicines as dietary supplements or classifying some as drugs requiring stricter testing and approval [19]. Herbal medicine con­tinues valuably blending antiquity’s wisdom with modern science for health and wellness.

13.1.2 ScOpe Of neurOlOgical diSeaSeS

Neurological diseases encompass a broad spectrum of disorders that affect the brain, spinal cord, and peripheral nervous system. These conditions can range from common ailments like migraines and epilepsy to more complex and debilitating diseases such as Alzheimer’s, Parkinson’s, multiple
FIGURE 13.1 Some prominent herbs with Medicinal properties.
Herbal Medicine and Neurological Diseases 289
sclerosis, and the motor neuron disease known as amyotrophic lateral sclerosis [20]. The scope of neurological diseases is vast due to the immense complexity of the human nervous system, which intricately controls and coordinates each and every one of the body’s innumerable functions [21]. These diseases hold the potential to impact motor skills, sensory awareness, cognition, behavior, and autonomic functions. Genetic predispositions, environmental exposures, infectious agents, physical traumas, or even etiologies that remain unknown – any of these triggers may underlie the origins of specic neurological disorders [22]. Treating and managing neurological diseases frequently demands an interdisciplinary clinical strategy, incorporating pharmaceutical interventions, physical and occupational therapies, psychological support services, and, in some cases, surgical options. Continual advances in scientic research serve to expand our fundamental understanding of these conditions, leading to enhanced diagnostic techniques, rened treatment protocols, and, in a few instances, even prospective preventative measures.

13.1.3 ratiOnale fOr explOring Herbal reMedieS

Exploring herbal remedies is a tradition rooted in humanity’s innate drive to heal itself through natural means whenever possible. This pursuit of gentler options includes several compelling ratio­nales [23]. The long cultural pedigree of many plants’ medical usages, as generations shared which species soothed what suffering. That enduring ethnobotanical paper trail hints some herbs warrant careful studies into whether tradition translates to treatment. Herbs are widely perceived as wielding fewer potential side effects than manufactured pharmaceuticals, a quality valued by those navigating delicate conditions or desiring delicate approaches [24–29]. Gentleness also means gentler remedies may complement conventions where those fall short. Herbalism often sees the person, rather than just the pathology, prioritizing overall wellness – a perspective increasingly popular as prevention, not just reaction, gains favor. Treating the whole being aligns with this holistic health model.
Bacteria’s accelerating resistance and the downsides of long- term medication lead to an urgent need for alternatives. Nature’s plants, whose compounds work in complex concert, may offer novel ways to manage persistent infections and persistent patients [30].
Modern technology enables scientists to extract and analyze the active elements of herbs, provid­ing valuable insights that can be applied to other elds such as medicine research and supplement formulation. This scientic validation has the potential to greatly enhance accessibility.
Herbal medicines are often more economically efcient and environmentally sensitive, which is particularly important when infrastructure is unreliable. Botanical medicine can be a crucial solution for populations that have limited access to healthcare services [31–33].
Although herbalism shows promise, it is crucial to prioritize rigorous study in order to establish the safety, effectiveness, and consistent benets of medicines.

13.2 NEUROPROTECTIVE EFFECTS OF HERBAL COMPOUNDS

Neuroprotective properties of herbal compounds pertain to the capacity of specic molecules pro­duced from plants to shield brain cells (neurons) against harm, deterioration, or demise [34]. The impact of these consequences is highly important in the context of neurological disorders such as Alzheimer’s, Parkinson’s, stroke, and multiple sclerosis. In these conditions, oxidative stress, inammation, and excitotoxicity play a crucial role in causing damage to neurons.

13.2.1 MecHaniSMS Of neurOprOtectiOn

13.2.1.1 Antioxidant Activity
Compounds abundant in antioxidants, such as curcumin from turmeric and the avonoids found in an assortment of fruits and vegetables, have demonstrated an ability to shelter neurons by scavenging damaging free radicals, which balances oxidative stress, a principal factor in neurodegeneration. Many plant extracts contain antioxidants that counteract free radicals and decrease oxidative stress [35–39].
290 Herbal Pharmacopeia
FIGURE 13.2 Potential mechanism of action of medicinal herbs.
13.2.1.2 Anti- inammatory Properties
Persistent irritation within the mind is a hallmark of many neurological issues. Certain herbal extracts, including resveratrol present in grapes and ginsenosides discovered in ginseng, exhibit anti- inammatory results through inhibiting the manufacturing of pro- inammatory cytokines and modulating immune responses, thereby decreasing neuronal injury [40]. Herbal compounds have also been proven to curb inammation in the mind, a hallmark of neurological issues (Figure 13.2).
13.2.1.3 Inhibition of Excitotoxicity
Excitotoxicity occurs when neurons are excessively stimulated by neurotransmitters such as gluta­mate, leading to cellular damage and death. Certain herbs include chemicals that can help control neurotransmitter levels, thereby reducing excitotoxic damage. For instance, Ginkgo biloba has com­ponents that help regulate neurotransmitter levels [41].
13.2.1.4 Enhancement of Neurogenesis and Synaptic Plasticity
Herbal extracts with positive effects promote the formation of new neurons, a process called neu­rogenesis, and enhance synaptic plasticity, which is crucial for learning, memory, and overall brain function. An example is the presence of bacosides in Bacopa monnieri, which have been examined for their capacity to improve cognitive functions by promoting neurogenesis and synaptic commu­nication [42–49].
13.2.1.5 Mitochondrial Protection
Neurodegenerative disorders have a particular impact on mitochondria, which are the cellular powerhouses responsible for generating energy. Research indicates that herbal substances such as
Herbal Medicine and Neurological Diseases 291
berberine found in goldenseal and quercetin found in various fruits and vegetables have the capacity to enhance mitochondrial activity and protect against energy deciencies in neurons.

13.2.2 rOle Of Oxidative StreSS in neurOlOgical diSeaSeS

Oxidative stress is a pivotal factor in the initiation and advancement of several neurological disor­ders. It arises from a disparity between the generation of reactive oxygen species (ROS) and the body’s capacity to counteract them with antioxidants [50]. This imbalance results in the buildup of reactive oxygen species (ROS), which can harm cellular structures, including DNA, proteins, and lipids. Neurons, in particular, are prone to oxidative damage because of their high oxygen consump­tion and inadequate antioxidant defenses.
13.2.2.1 Essential Components of Oxidative Stress in Neurological Disorders
13.2.2.1.1 Impaired Functioning of Mitochondria
Neurons are highly dependent on mitochondria for their energy needs. Oxidative stress- induced damage to mitochondria results in decreased energy production and further amplies the creation of reactive oxygen species (ROS), establishing a detrimental loop of damage that contributes to dementia. Oxidative stress has the potential to induce genetic mutations in DNA and alter proteins, thereby interfering with their regular functioning. This damage might result in cellular impairment and demise, hence exacerbating the advancement of neurological disorders [51–54]. Lipid peroxi­dation occurs when ROS target and damage lipids found in cell membranes, especially in the brain where there is a high concentration of polyunsaturated fatty acids. Lipid peroxidation is the process that causes damage to the cell membrane, resulting in the loss of cell integrity and ultimately leading to the death of neurons.
13.2.2.1.2 Neurological Disorders Linked to Oxidative Stress
Alzheimer’s disease: Oxidative stress has a role in the development of beta- amyloid plaques and tau tangles, which are characteristic features of Alzheimer’s disease and are linked to the loss of neurons and deterioration in cognitive function.
Parkinson's disease: Oxidative stress contributes to the deterioration of dopaminergic neurons
in the substantia nigra in Parkinson’s disease, primarily as a result of the oxidative break­down of dopamine [55].
Amyotrophic lateral sclerosis (ALS): The breakdown of motor neurons is associated with oxi-
dative stress, in which mutations in antioxidant enzymes such as superoxide dismutase 1 (SOD1) have a notable impact.
Multiple sclerosis (MS): Oxidative stress worsens inammation and demyelination in MS,
causing additional harm to neurons and advancing the disease.
Stroke: The occurrence of a stroke leads to a signicant increase in ROS due to the damage
caused by the interruption and restoration of blood ow. This surge in ROS results in sub­stantial damage to the neurons, which worsens the severity of the injury [56].
Therapeutic implications: The comprehension of oxidative stress in neurological disorders
has generated curiosity in antioxidant treatments designed to diminish oxidative harm and decelerate the advancement of the condition. Nevertheless, the intricate nature of oxida­tive stress pathways in the brain poses difculties, necessitating further research to devise efcacious treatments.

13.2.3 anti- inflaMMatOry prOpertieS Of Herbal cOMpOundS

The varied anti- inammatory capacities of herbal substances have long been acknowledged for their notable part in managing and forestalling diverse inammatory issues, including those impacting
292 Herbal Pharmacopeia
the sensory system [57]. These chemicals can impede irritation through different instruments, giving a common elective or expansion to conventional anti- inammatory medications.
13.2.3.1 Anti- Inammatory Activity Systems
Suppression of pro- inammatory cytokines: Certain herbs like curcumin derived from turmeric and resveratrol found in grapes have appeared capable of diminishing the combination of pro­inammatory cytokines like TNF- α, IL- 1β, and IL- 6. By suppressing these signaling particles, they help in diminishing cellular irritation [58].
The NF- κB pathway plays a key job in controlling the inammatory reaction. A few herbal sub- stances, like gingerol found in ginger and epigallocatechin gallate (EGCG) from green tea, have the capacity to block the initiation of NF- κB, bringing about a decrease in the articulation of qualities related with swelling.
Antioxidant effects: Oxidative pressure and aggravation are rmly intertwined, as responsive
oxygen types (ROS) frequently start inammatory pathways. Herbal substances contain­ing intense antioxidants, like quercetin present in different natural products and vegeta­bles and avonoids, help in diminishing oxidative pressure, subsequently diminishing irritation.
Suppression of COX and LOX enzymes: The inammatory process is impacted by the creation
of pro- inammatory mediators, for example, prostaglandins and leukotrienes, which are created by enzymes called cyclooxygenase (COX) and lipoxygenase (LOX) [59]. Blends like boswellic corrosive, obtained from frankincense, and salicin, extracted from willow bark, have the capacity to impede these enzymes, along these lines diminishing irritation.
Immune system modulation: Certain herbs have an inherent ability to govern the immune reac-
tion by upholding equilibrium between pro- and anti- inammatory signals. For example, ginsenosides derived from ginseng and complex sugars obtained from fungi such as reishi have the potential to better immunological regulation, thereby facilitating a more balanced inammatory feedback.
13.2.3.2 Uses and Advantages
Chronic Inammatory Illnesses: Herbal anti- inammatory agents are commonly applied to
manage persistent inammatory conditions – for example, rheumatoid arthritis, inamma­tory bowel disease, and asthma [60–64]. They have the possibility to diminish the necessity for the extended application of standard anti- inammatory medications, which can result in notable adverse effects.
Neurological Disorders: Inammation plays a crucial part in neurodegenerative diseases
such as Alzheimer’s, Parkinson’s, and multiple sclerosis. Herbal ingredients with anti­inammatory qualities own the ability to retard the progression of illnesses and provide relief from symptoms. Herbal compounds are often employed to treat inammatory skin disor­ders, such as eczema, psoriasis, and dermatitis, due to their relaxing and anti- inammatory properties.
Cardiovascular Health: Enduring inammation notably contributes to the evolution of car-
diovascular sicknesses. Herbal ingredients possess the ability to mitigate inammation in blood vessels, hence decreasing the prospect of atherosclerosis and related ailments.
The therapeutic potential of herbal components is substantiated by both ancestral usage and modern scientic investigation, owing to their anti- inammatory traits. Although they have possible healing benets, it is crucial to approach their application with an appreciation of suitable dosage, potential interactions with other medications, and the necessity for extra analysis to substantiate effectiveness and safety in specic circumstances.
Herbal Medicine and Neurological Diseases 293

13.2.4 regulatiOn Of neurOnal apOptOSiS by Herbal reMedieS

Promising research has also been carried out on the ability of certain herbal remedies to regulate neuronal apoptosis (programmed cell death) in respect of neurodegenerative diseases where exces­sive or dysregulated apoptosis plays a part in the attrition of neurons [65]. Indeed, some herbal com­pounds have been found to positively modulate apoptotic pathways, leading to neuronal survival, and may be useful for promoting brain health (Figure 13.3).
For example, herbal compounds such as curcumin (from turmeric) and ginsenosides (ginseng) are found to inhibit pro- apoptotic proteins such as Bax, caspases, cytochrome c which, upon inhibi­tion, reduce the markers of the apoptosis pathway, and hence prohibiting triggering an event to prevent the death of neurons.
Activation of Anti- apoptotic Pathways: Some herbal remedies increase the levels of anti-
apoptotic proteins such as Bcl- 2 (together with decreasing, for example, Bak), which sta­bilize mitochondria and inhibit apoptosis signals. Compounds like resveratrol (found in grapes) and epigallocatechin gallate, or EGCG for short (from green tea), have been shown to turn on these protective pathways.
Reducing Oxidative Stress: In the brain, one of the main stimulants for neuronal apoptosis is
oxidative stress. The strong antioxidant properties of some herbal compounds like querce­tin, avonoids neutralize the ROS and thus reduced oxidative damage preventing apoptosis.
Modulation of Signaling Pathways: Herbal compounds can modulate important signaling
pathways responsible for apoptosis, e.g., MAPK/ERK pathway, PI3/Akt and JNK. For example, various phytochemicals (baicalin from Sc), and honokiol (from Mo) were shown to act on this pathway protecting neurons by activation of survival genes and preventing the induction of death cell osteosis [66–68].
FIGURE 13.3 Mechanisms involved in the regulation of neuronal apoptosis by herbal medicines.